DBV Technologies | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amarin USD 305.2M 156K 2024-09
BioMarin Pharmaceutical USD 192K 1000 2025-03
DBV Technologies USD 10.98M 1000 2024-09
Halozyme Therapeutics USD 123K 0 2025-03
Incyte USD 193K 0 2025-03
Insmed USD 1.82M 25K 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
PTC Therapeutics USD 78K 1000 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 0 2025-03



DBV Technologies Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.